glipizide has been researched along with Factitious Disorders in 1 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
Factitious Disorders: Disorders characterized by physical or psychological symptoms that are not real, genuine, or natural.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sener, A | 1 |
| Gillet, C | 1 |
| Verhelst, J | 1 |
| DeBoeck, K | 1 |
| Mahler, C | 1 |
| Malaisse, WJ | 1 |
1 other study available for glipizide and Factitious Disorders
| Article | Year |
|---|---|
Factitious hypoglycaemia documented by a modified assay for the measurement of plasma sulphonylurea.
Topics: Adult; Factitious Disorders; Female; Glipizide; Humans; Hypoglycemia; Male | 1995 |